Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination

被引:53
|
作者
Zhang, Jinghui [1 ]
Wang, Haoxun [1 ]
Fan, Yunzhou [1 ]
Yu, Zhou [1 ]
You, Guofeng [1 ]
机构
[1] Rutgers State Univ, Dept Pharmaceut, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA
关键词
Drug transporter; Organic anion transporter; Drug disposition; Post-translational modification; Regulation; PROTON PUMP INHIBITORS; RENAL CLEARANCE; INDOXYL SULFATE; IN-VITRO; POSTTRANSLATIONAL MODIFICATIONS; TRANSCRIPTIONAL REGULATION; HEPATOCELLULAR-CARCINOMA; CATION TRANSPORTERS; SUMO MODIFICATION; P-AMINOHIPPURATE;
D O I
10.1016/j.pharmthera.2020.107647
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The members of the organic anion transporter (OAT) family are mainly expressed in kidney, liver, placenta, intestine, and brain. These transporters play important roles in the disposition of clinical drugs, pesticides, signaling molecules, heavy metal conjugates, components of phytomedicines, and toxins, and therefore critical for maintaining systemic homeostasis. Alterations in the expression and function of OATs contribute to the intra- and inter-individual variability of the therapeutic efficacy and the toxicity of many drugs, and to many pathophysiological conditions. Consequently, the activity of these transporters must be highly regulated to carry out their normal functions. This review will present an update on the recent advance in understanding the cellular and molecular mechanisms underlying the regulation of renal OATs, emphasizing on the post-translational modification (PTM), the crosstalk among these PTMs, and the remote sensing and signaling network of OATs. Such knowledge will provide significant insights into the roles of these transporters in health and disease. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Physiology, structure, and regulation of the cloned organic anion transporters
    Srimaroeng, C.
    Perry, J. L.
    Pritchard, J. B.
    XENOBIOTICA, 2008, 38 (7-8) : 889 - 935
  • [2] Organic Anion Transporters: Discovery, Pharmacology, Regulation and Roles in Pathophysiology
    VanWert, Adam L.
    Gionfriddo, Michael R.
    Sweet, Douglas H.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2010, 31 (01) : 1 - 71
  • [3] Regulation of organic anion and drug transporters of the sinusoidal membrane
    Kullak-Ublick, GA
    JOURNAL OF HEPATOLOGY, 1999, 31 (03) : 563 - 573
  • [4] Role of organic cation transporters in drug absorption and elimination
    Zhang, L
    Brett, CM
    Giacomini, KM
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1998, 38 : 431 - 460
  • [5] Transporters involved in the elimination of drugs in the kidney: Organic anion transporters and organic cation transporters
    Dresser, MJ
    Leabman, MK
    Giacomini, KM
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (04) : 397 - 421
  • [6] Molecular physiology of renal organic anion transporters
    Sekine, T
    Miyazaki, H
    Endou, H
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (02) : F251 - F261
  • [7] Update on the molecular physiology of organic anion transporters
    Ahn, Sun-Young
    Bhatnagar, Vibha
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2008, 17 (05): : 499 - 505
  • [8] Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides
    Lee, Wooin
    Ha, Jeong-min
    Sugiyama, Yuichi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (50) : 17349 - 17364
  • [9] The role of hepatic transporters in drug elimination
    Funk, Christoph
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (04) : 363 - 379
  • [10] Endocrine regulation of rat organic anion transporters
    Buist, SCN
    Cherrington, NJ
    Klaassen, CD
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (05) : 559 - 564